Activating complex regions of the genome to treat rare diseases: Researchers identify a a ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...
The EMBO Journal5 天
A CRISPR-Cas9 screen reveals genetic determinants of the cellular response to decitabine
A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...